SCHEMBL20429347

SCHEMBL20429347

Cc1cc(C)cc(C(=O)Oc2ccc(C(C)CN3CCN(CC4CC4)CC3)cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.38
OPRK1 P41145 1/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 1/20 0.38
HRH1 P35367 2/20 0.37
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
HRH2 P25021 1/20 0.37
KDM2B Q8NHM5 4/20 0.36
CCR3 P51677 1/20 0.36
KCNH2 Q12809 1/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
NR1I2 O75469 1/20 0.36
HTR3B O95264 1/20 0.36
HTR3A P46098 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8511443 0.76 ROCK2 (0.70) ROCK2
SCHEMBL14461699 0.75 ALDH1A1 (0.50) ROCK2MAPTRAB9AMEN1KMT2A
SCHEMBL23453298 0.64 POLB (0.51) MAPTRAB9AKMT2A
SCHEMBL17208294 0.63 KMT2A (0.51) MAPTRAB9AMEN1CYP1A2CYP2C19
SCHEMBL21214474 0.63 ALDH1A1 (0.65) MAPTOPRM1OPRD1KDM2BMEN1
SCHEMBL17208293 0.63 ESR2 (0.45) MAPTRAB9AMEN1CYP1A2CYP2D6
SCHEMBL8421936 0.63 NSD2 (0.62) MAPTMEN1CYP1A2CYP2C19KMT2A
SCHEMBL13296203 0.62 ALDH1A1 (0.50) MAPTRAB9AMEN1KMT2A
SCHEMBL5073854 0.62 L3MBTL1 (0.48) RAB9ACYP2C19KMT2A
SCHEMBL27844769 0.62 ALDH1A1 (0.49) MAPTKCNH2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354643-B1 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE AERIE PHARMACEUTICALS INC (US) 2020-10-28 EP disclosed
EP-3354643-A1 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2018-08-01 EP disclosed